Heather Gros
Acute Care · Covington, LANPI 1881167039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,248 and has fallen 57.9% since, to $525 in 2025.
Across 220 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$434
- Kestra Medical Technology Services, Inc.$413
- Novartis$403
- E.r. Squibb & Sons, L.L.C.$384
- Merck$373
- Johnson & Johnson$327
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,299100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $434 |
| Kestra Medical Technology Services, Inc. | 15 | $413 |
| Novartis | 29 | $403 |
| E.r. Squibb & Sons, L.L.C. | 20 | $384 |
| Merck | 22 | $373 |
| Johnson & Johnson | 20 | $327 |
| Amgen | 21 | $313 |
| Impulse Dynamics (USA) Inc. | 4 | $258 |
| Sanofi-aventis U.S. LLC | 13 | $233 |
| Esperion Therapeutics, Inc. | 18 | $231 |
| AstraZeneca | 13 | $184 |
| Inspire Medical Systems, Inc. | 1 | $122 |
| Pfizer | 5 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $83 |
| Boehringer Ingelheim | 5 | $74 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Scpharmaceuticals Inc. | 3 | $58 |
| Boston Scientific | 2 | $52 |
| Edwards Lifesciences | 1 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $32 |
| BTG International Inc. | 1 | $22 |
| GSK | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,299 in reported general payments places this provider in the 85th percentile of 248 acute care providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 334 | $212,757 |
| Repatha SureclickEvolocumab | 25 | $27,879 |
| EntrestoSacubitril/Valsartan | 23 | $26,090 |
| XareltoRivaroxaban | 32 | $25,290 |
| JardianceEmpagliflozin | 16 | $12,318 |
| NexletolBempedoic Acid | 12 | $6,371 |
| SotalolSotalol Hcl | 341 | $5,310 |
| NexlizetBempedoic Acid/Ezetimibe | 11 | $4,582 |
| Ranolazine ErRanolazine | 20 | $2,755 |
| Metoprolol Succinate | 244 | $2,289 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 70 | $1,590 |
| Olmesartan Medoxomil | 114 | $1,447 |
| Flecainide Acetate | 70 | $1,184 |
| Enoxaparin Sodium | 15 | $1,052 |
| Rosuvastatin Calcium | 119 | $1,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $104 | $212,757334 claims |
| NovartisEntresto | $403 | $26,09023 claims |
| Johnson & JohnsonXarelto | $327 | $25,29032 claims |
| Boehringer IngelheimJardiance | $74 | $12,31816 claims |
| Esperion Therapeutics, Inc.Nexletol, Nexlizet | $231 | $10,95323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 248 acute care providers in Louisiana.
Other acute care in Covington
- Danielle TranchinaCovington$8K
- Molly PeckCovington$4K
- Lisa Raymond-PrinzCovington$3K
- Holly LeonhardCovington$2K
- Precious HodgesLafayette$70K
- Brinton FegleyShreveport$61K
- Charles JarreauNew Orleans$40K
- Jeremy DavisShreveport$35K
- Heather MecomShreveport$17K
- Jeremy TerroLafayette$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.